Hims & Hers Health, Inc. (HIMS) Misses Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides First Quarter and Full Year 2022 Outlook
February 22, 2022 4:06 PM ESTExceeded Q4 2021 and full year 2021 revenue and Adjusted EBITDA guidance
Full year revenue grew 83% year-over-year to $271.9 million. Q4 2021 revenue increased from Q3 2021 and grew 104% year-over-year to $84.7 million
Q4 2021 ending member subscriptions grew 95% year-over-year to 609,000
Provides Q1 and full year 2022 guidance, with full year 2022 revenue in the range of $365 million to $380 million and Adjusted EBITDA in the range of $(30) million to $(20) million
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (Hims & Hers, NYSE: HIMS), a multi-specialty telehealth platform that connects... More



